{"url_path":"/sec/bfriw/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1858685/0001493152-26-023119-index.html","accession_number":"0001493152-26-023119","cik":"0001858685","ticker":"BFRI","issuer_name":"Biofrontera Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1858685/0001493152-26-023119-index.html","primary_entity_key":"0001858685","primary_entity_name":"Biofrontera Inc."},"word_count":229,"has_tables":true,"body_markdown":"**Item\n6. Exhibits** \n\n \n\nThe\nfollowing exhibits are filed herewith or are incorporated by reference to exhibits previously filed with the SEC.\n\n \n\n**Exhibit No.**\n \n \n\n \n \n \n\n31.1*\n \n[Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n\n \n \n \n\n31.2*\n \n[Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm)\n\n \n \n \n\n32.1*\n \n[Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n \n \n \n\n32.2*\n \n[Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002](ex32-2.htm)\n\n \n \n \n\n101.INS*\n \nInline XBRL Instance Document\n\n \n \n \n\n101.SCH*\n \nInline XBRL Taxonomy Extension Schema Document\n\n \n \n \n\n101.CAL*\n \nInline XBRL Taxonomy Extension Calculation Linkbase Document\n\n \n \n \n\n101.DEF*\n \nInline XBRL Taxonomy Extension Definition Linkbase Document\n\n \n \n \n\n101.LAB*\n \nInline XBRL Taxonomy Extension Label Linkbase Document\n\n \n \n \n\n101.PRE*\n \nInline XBRL Taxonomy Extension Presentation Linkbase Document\n\n \n \n \n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document and included in Exhibit 101)\n\n \n\n*\nFiled\nherewith.\n\n \n\n31\n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its\nbehalf by the undersigned thereunto duly authorized.\n\n \n\n \nBIOFRONTERA\nINC.\n\n \n \n \n\nDate:\nMay 14, 2026\nBy:\n*/s/\nHermann Luebbert*\n\n \nName:\n\nHermann\nLuebbert\n\n \nTitle:\n\nChief\nExecutive Officer & Chairman\n\n(*Principal\nExecutive* *Officer*)\n\n \n \n \n\nDate:\nMay 14, 2026\nBy:\n*/s/\nE. Fred Leffler, III*\n\n \nName:\n\nE.\nFred Leffler, III\n\n \nTitle:\n\nChief\nFinancial Officer\n\n*(Principal\nFinancial Officer)*\n\n \n\n32"}